SCHEMBL870169

SCHEMBL870169

CC(C)(C)c1ccc(-c2c3ccc(C(C)(C)C)cc3c(-c3ccc(C(C)(C)C)cc3)c3c(-c4ccc(C(C)(C)C)cc4)c4ccc(C(C)(C)C)cc4c(-c4ccc(C(C)(C)C)cc4)c23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 7/20 0.41
TSHR P16473 1/20 0.38
ALDH1A1 P00352 3/20 0.38
HPGD P15428 1/20 0.38
ALOX15 P16050 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
LMNA P02545 1/20 0.37
TYR P14679 1/20 0.37
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
KMT2A Q03164 2/20 0.36
MITF O75030 1/20 0.36
TP53 P04637 1/20 0.36
MEN1 O00255 1/20 0.34
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34
PKM P14618 1/20 0.34
RECQL P46063 1/20 0.34
KDM4E B2RXH2 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29380358 0.93 KIF11 (0.41) KIF11ALDH1A1NPC1RAB9AKMT2A
SCHEMBL475529 0.93 KIF11 (0.41) KIF11ALDH1A1NPC1RAB9AKMT2A
SCHEMBL2128621 0.91 KIF11 (0.41) KIF11ALDH1A1MAPTGPR84
SCHEMBL17141425 0.91 KIF11 (0.44) KIF11ALDH1A1NPC1RAB9ATP53
SCHEMBL13499842 0.91 KIF11 (0.47) KIF11
SCHEMBL12928317 0.91 MEN1 (0.42) KIF11ALDH1A1HPGDALOX15HSD17B10
SCHEMBL13499843 0.88 MAPT (0.43) ALDH1A1ALOX15HSD17B10TDP1LMNA
SCHEMBL14521770 0.84 SERPINE1 (0.36) KIF11ALDH1A1MAPTGPR84
SCHEMBL3866832 0.83 KIF11 (0.43) KIF11TSHRALDH1A1LMNATYR
SCHEMBL23567208 0.83 GPR84 (0.41) KIF11LMNAKMT2ATP53MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3561876-B1 DISPLAY NOVALED GMBH (DE) 2022-02-16 EP disclosed
EP-3561876-A1 DISPLAY Novaled GmbH (DE) 2019-10-30 EP disclosed
US-10396293-B2 Electronic or optoelectronic device comprising an anchored thin molecular layer, process for its preparation and compound used therein NOVALED GMBH (DE) 2019-08-27 US disclosed
EP-2786435-B1 Compounds NOVALED GMBH (DE) 2019-07-17 EP disclosed
EP-2840622-B1 Electronic or optoelectronic device comprising an anchored thin molecular layer, process for its preparation and compound used therein NOVALED GMBH (DE) 2019-02-13 EP disclosed
US-9722183-B2 Display NOVALED GMBH (DE) 2017-08-01 US disclosed
US-20160211461-A1 Electronic or Optoelectronic Device Comprising an Anchored Thin Molecular Layer, Process for its Preparation and Compound Used Therein NOVALED GMBH (DE) 2016-07-21 US disclosed
EP-2840622-A1 Electronic or optoelectronic device comprising an anchored thin molecular layer, process for its preparation and compound used therein Novaled GmbH (DE) 2015-02-25 EP disclosed
US-20140332790-A1 Display NOVALED GMBH (DE) 2014-11-13 US disclosed
US-8637858-B2 Tandem white OLED NOVALED AG (DE) 2014-01-28 US disclosed
US-20120074392-A1 Tandem White OLED NOVALED AG (DE) 2012-03-29 US disclosed
US-7662485-B2 White organic light-emitting devices with improved performance EASTMAN KODAK COMPANY (US) 2010-02-16 US disclosed
EP-1725631-B1 WHITE ORGANIC LIGHT-EMITTING DEVICES WITH IMPROVED PERFORMANCE EASTMAN KODAK CO (US) 2008-04-23 EP disclosed
EP-1725631-A1 WHITE ORGANIC LIGHT-EMITTING DEVICES WITH IMPROVED PERFORMANCE EASTMAN KODAK COMPANY (US) 2006-11-29 EP disclosed
WO-2005093008-A1 WHITE ORGANIC LIGHT-EMITTING DEVICES WITH IMPROVED PERFORMANCE EASTMAN KODAK COMPANY (US) 2005-10-06 WO disclosed
US-20050208327-A1 White organic light-emitting devices with improved performance GLOBAL OLED TECHNOLOGY LLC 2005-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160211461-A1 Electronic or Optoelectronic Device Comprising an Anchored Thin Molecular Layer, Process for its Preparation and Compound Used Therein EPCAM, OR10J3, OR51E2 KIF11 2243/4885TSHR 3765/4885ALDH1A1 1046/4885
US-10396293-B2 Electronic or optoelectronic device comprising an anchored thin molecular layer, process for its preparation and compound used therein EPCAM, OR10J3, OR51E2 KIF11 2243/4885TSHR 3765/4885ALDH1A1 1046/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.